2025年05月22日 星期四 首页   |   期刊介绍   |   编 委 会   |   投稿指南   |   期刊订阅   |   广告合作   |   联系我们   |   ENGLISH
哈尔滨医药  2023, Vol. 43 Issue (6): 9-11    DOI: 10.3969/j.issn.1001-8131.2023.06.004
  论著 本期目录 | 过刊浏览 | 高级检索 |
增强MSCT在超声引导下小肝癌射频消融术疗效评估中的应用观察
黄海珅
郑州市第七人民医院介入手术室, 河南 郑州 450000
Application of Enhanced MSCT in Hepatocellular Carcinoma Ultrasound-guided Radiofrequency Ablation Treatment of Small Liver Cancer
Huang Haishen
Interventional Operating Room, Zhengzhou No.7 People's Hospital, Zhengzhou 450000, Henan Province, China
全文: PDF (560 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探究增强多层螺旋CT(MSCT)在超声引导下小肝癌射频消融术疗效评估中的应用。方法 选择于我院接受超声引导下射频消融术治疗的136例小肝癌患者, 患者术后1个月均进行增强MSCT检查及数字减影血管造影(DSA)检查, 以DSA检查结果为金标准, 评价增强MSCT评估疗效的效能。结果 136例患者176个病灶射频消融术后1个月DSA检查显示完全消融119个, 存在残留病灶57个, 经增强MSCT检查显示完全消融120个, 存在残留病灶56个, 增强MSCT评价消融疗效的敏感度为70.17%, 特异度为86.55%, 准确率为81.25%, 阳性预测值为71.43%, 阴性预测值为85.83%, Kappa=0.570, 与DSA检查结果具有较好一致性。结论 进行增强MSCT扫描能够清晰观察超声引导下小肝癌射频消融术后患者病灶变化, 有效评价疗效, 指导后续治疗。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
黄海珅
关键词 增强MSCT超声引导小肝癌射频消融术疗效评估    
AbstractObjective To explore the application of enhanced multi-slice spiral CT(MSCT)in the evaluation of efficacy of ultrasound-guided radiofrequency ablation for small liver cancer. Methods 136 patients with small liver cancer who underwent ultrasound-guided radiofrequency ablation were selected in our hospital.All patients underwent enhanced MSCT examination and digital subtraction angiography(DSA)examination at 1 month after surgery.DSA examination Results were taken as the gold standards to assess the efficiency of enhanced MSCT in evaluating efficacy. Results Among 136 patients with 176 lesions at 1 month after radiofrequency ablation, DSA examination showed 119 lesions of complete ablation and 57 residual lesions, and enhanced MSCT examination showed 120 lesions of complete ablation and 56 residual lesions.The sensitivity, specificity, accuracy rate, positive predictive value, negative predictive value and Kappa value of enhanced MSCT in evaluating the ablation efficacy were 70.17%, 86.55%, 81.25%, 71.43%, 85.83% and 0.570, which had good consistency with the DSA detection results. Conclusion Enhanced MSCT scan can clearly observe the changes of lesions of patients after ultrasound-guided radiofrequency ablation for small liver cancer, and can effectively evaluate the efficacy and guide subsequent treatment.
Key wordsEnhanced MSCT    Ultrasound-guided    Radiofrequency ablation for small liver cancer    Efficacy evaluation
收稿日期: 2022-12-20     
PACS:  R735.17  
引用本文:   
黄海珅. 增强MSCT在超声引导下小肝癌射频消融术疗效评估中的应用观察[J]. 哈尔滨医药, 2023, 43(6): 9-11.
Huang Haishen. Application of Enhanced MSCT in Hepatocellular Carcinoma Ultrasound-guided Radiofrequency Ablation Treatment of Small Liver Cancer. journal1, 2023, 43(6): 9-11.
链接本文:  
http://www.hrbyybjb.org.cn/CN/10.3969/j.issn.1001-8131.2023.06.004     或     http://www.hrbyybjb.org.cn/CN/Y2023/V43/I6/9
版权所有 © 《哈尔滨医药》编辑部  备案号: 黑ICP备19005758号-1
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn